Low-dose Btk inhibitors: an 'aspirin' of tomorrow?

Haematologica. 2021 Jan 1;106(1):2-4. doi: 10.3324/haematol.2020.265173.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Agammaglobulinaemia Tyrosine Kinase
  • Aspirin*
  • Humans
  • Lectins, C-Type
  • Platelet Activation
  • Protein Kinase Inhibitors*

Substances

  • Lectins, C-Type
  • Protein Kinase Inhibitors
  • Agammaglobulinaemia Tyrosine Kinase
  • Aspirin